http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107750157-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30 |
filingDate | 2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107750157-B |
titleOfInvention | orodispersible tablet containing estritol |
abstract | The present invention provides an orodispersible solid pharmaceutical dosage unit with a weight of 30-1000 mg, the dosage unit contains at least 100 μg of an estradiol component selected from estriol, estrol esters and combinations thereof; wherein the solid dosage unit It can be obtained by a method comprising: providing an aqueous liquid comprising water, an estritol component and optionally one or more other pharmaceutically acceptable ingredients; mixing 1 part by weight of the aqueous liquid with 0.5-20 parts by weight of the carrier granules are mixed to produce wet granules; water is removed from the wet granules to produce loaded granules; optionally the loaded granules are mixed with one or more tabletting excipients; and The loaded granules or mixtures of loaded granules and the one or more tabletting excipients are formed into solid dosage units. The solid dosage unit is easy to manufacture and well suited for sublingual, buccal or sublabial administration. |
priorityDate | 2015-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.